{
    "url_original": "https://www.wsj.com/articles/promising-covid-19-pill-licensed-to-u-n-backed-nonprofit-to-increase-global-supplies-11635328800?mod=business_lead_pos2",
    "url": "promising-covid-19-pill-licensed-to-u-n-backed-nonprofit-to-increase-global-supplies-11635328800",
    "title": "Promising Covid-19 Pill Licensed to U.N.-Backed Nonprofit to Increase Global Supplies",
    "sub_head": "Merck is licensing molnupiravir to a group that will pick drugmakers to make the pill for low- and middle-income countries",
    "category_1": "Business",
    "category_2": "Health Care",
    "image_1_url": "https://images.wsj.net/im-424082?width=860&height=573",
    "image_1": "im-424082.jpg",
    "time": "2021-10-27 06:00:00",
    "body": "Merck  & Co. will license a promising Covid-19 drug to a United Nations-backed nonprofit to provide more supplies to low- and middle-income countries.<br />The Medicines Patent Pool, which aims to expand poor countriesâ€™ access to drugs, will work with multiple drugmakers to produce molnupiravir for 105 nations, including Pakistan, Cambodia and all of Africa, the company and nonprofit said Wednesday."
}